On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.
More Latest News
May 4, 2017
Registrations expire on June 30, 2017, Ready to Renew? Click here for information for renewing your registration. Continue reading
May 3, 2017
Attention: The Board of Optometry will be holding a special telephone meeting on May 11th, at 9:00 AM… Continue reading